Cannabis Countdown: Top 10 Marijuana Industry News Stories of the Week
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana industry news stories for the week of October 14th – 20th, 2019.
Without further ado, let’s get started.
Red White & Bloom RWB IPO Soon)) CEO Brad Rogers to Highlight Biggest Cannabis Investing Event of the Year
TCI investors will receive 20% off their ticket purchases when they use our discount code. See the link below for code.
9. Colorado Proposes Rules to Ban Additives in Cannabis Vape Products
Colorado Regulators are Finalizing Rules to Ban Certain Ingredients From Marijuana Vape Products
At a public hearing Tuesday, Colorado’s Marijuana Enforcement Division discussed the proposed rules that would prohibit the use of the following ingredients in cannabis concentrates or products used for inhalation:
READ FULL COLORADO VAPES ARTICLE
8. Cannabis Industry Contributed to Spike in Home Prices, Housing Shortages
An Unintended Consequence of Employment Growth is a Shortage of Available Homes
Canada’s booming cannabis industry has led to a spike in housing prices and home shortages in some regions, according to a new report from RE/MAX. For example, Smiths Falls, Ont. — home to Canopy Growth WEED CGC, which Bloomberg dubbed the largest cannabis producer in the world — now employs 1,300 people.
READ FULL HOUSING SHORTAGE ARTICLE
7. Mexican Committees Unveil Marijuana Legalization Bill Ahead of Supreme Court Deadline
Several Mexican Senate Committees Unveiled Draft Legislation to Legalize Marijuana
Leaders of the Health, Justice, Public Security and Legislative Studies Committees announced last week that they would remain in permanent session to finalize the legalization bill ahead of a coming Supreme Court deadline.
READ FULL MEXICO CANNABIS ARTICLE
6. Alberta, Manitoba and Saskatchewan are Selling More Cannabis Than the Rest of Canada
Expert Says, “They are Making Ontario and Quebec Look Very Bad”
Alberta, Manitoba and Saskatchewan are selling more cannabis than the rest of Canada due to a better framework, according to one industry expert.
READ FULL CANADA CANNABIS SALES ARTICLE
5. Two More Studies Show Patients Are Replacing Prescription Painkillers With Marijuana
The Findings are the Latest in a Growing Body of Research on Cannabis’ Potential to Help Address the Opioid Crisis
Two new studies out this month offer additional evidence that chronic pain patients are skipping addictive pharmaceuticals and using marijuana instead to help them find relief.
READ FULL OPIOID CRISIS ARTICLE
4. $1.1 Billion Worth of Cannabis Sold in Canada’s First Year of Legalization
Statistics Canada Says Licensed Retail Outlets Sold More Than $100 Million Worth of Pot in July
One year after the legalization of recreational cannabis, Cannabis Benchmarks, a company that tracks cannabis prices, estimates that Canadian licensed producers have sold approximately 1.1 billion dollars worth of pot in the past 12 months, the equivalent to 105,000 kilograms—enough to fill almost two rail freight cars.
READ FULL CANNABIS CANADA ARTICLE
3. Cannabis Edibles are Legal Now. Here’s What You Need to Know
Here is What You Should Know About the New Regulations
Exactly one year after Canada legalized the recreational use of marijuana, new rules are now in effect governing the production and sale of cannabis edibles, extracts and topicals such as lotions.
READ FULL LEGALIZATION 2.0 ARTICLE
2. U.S. Retail Sales of CBD May Increase 133% in 2019, Surpass $10 Billion by 2024
Since Passage of Farm Bill, CBD Products Have Exploded in Popularity and Retail Presence
Retail sales of CBD in the United States are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales – and might eclipse $10 billion by 2024, according to projections from the newly released 2019 Hemp & CBD Industry Factbook.
READ FULL U.S. CBD SALES ARTICLE
1. Lab Tests Suggest Vape Crisis May Be Result of Heavy Metal Fumes
Part 1 of a 3 Part Study Points to Metal Fume Fever as the Likely Culprit
While there has been speculation that the growing number of vape-related respiratory illnesses (1,300 and counting) and deaths (29 and counting) as a result of illicit and unregulated products, there now appears to be some science to back it up.
Image Sourced from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.